Cargando…
Quantitative plasma profiling by (1)H NMR-based metabolomics: impact of sample treatment
Introduction: There is evidence that sample treatment of blood-based biosamples may affect integral signals in nuclear magnetic resonance-based metabolomics. The presence of macromolecules in plasma/serum samples makes investigating low-molecular-weight metabolites challenging. It is particularly re...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273206/ https://www.ncbi.nlm.nih.gov/pubmed/37333016 http://dx.doi.org/10.3389/fmolb.2023.1125582 |
_version_ | 1785059646761861120 |
---|---|
author | Madrid-Gambin, Francisco Oller, Sergio Marco, Santiago Pozo, Óscar J. Andres-Lacueva, Cristina Llorach, Rafael |
author_facet | Madrid-Gambin, Francisco Oller, Sergio Marco, Santiago Pozo, Óscar J. Andres-Lacueva, Cristina Llorach, Rafael |
author_sort | Madrid-Gambin, Francisco |
collection | PubMed |
description | Introduction: There is evidence that sample treatment of blood-based biosamples may affect integral signals in nuclear magnetic resonance-based metabolomics. The presence of macromolecules in plasma/serum samples makes investigating low-molecular-weight metabolites challenging. It is particularly relevant in the targeted approach, in which absolute concentrations of selected metabolites are often quantified based on the area of integral signals. Since there are a few treatments of plasma/serum samples for quantitative analysis without a universally accepted method, this topic remains of interest for future research. Methods: In this work, targeted metabolomic profiling of 43 metabolites was performed on pooled plasma to compare four methodologies consisting of Carr-Purcell-Meiboom-Gill (CPMG) editing, ultrafiltration, protein precipitation with methanol, and glycerophospholipid solid-phase extraction (g-SPE) for phospholipid removal; prior to NMR metabolomics analysis. The effect of the sample treatments on the metabolite concentrations was evaluated using a permutation test of multiclass and pairwise Fisher scores. Results: Results showed that methanol precipitation and ultrafiltration had a higher number of metabolites with coefficient of variation (CV) values above 20%. G-SPE and CPMG editing demonstrated better precision for most of the metabolites analyzed. However, differential quantification performance between procedures were metabolite-dependent. For example, pairwise comparisons showed that methanol precipitation and CPMG editing were suitable for quantifying citrate, while g-SPE showed better results for 2-hydroxybutyrate and tryptophan. Discussion: There are alterations in the absolute concentration of various metabolites that are dependent on the procedure. Considering these alterations is essential before proceeding with the quantification of treatment-sensitive metabolites in biological samples for improving biomarker discovery and biological interpretations. The study demonstrated that g-SPE and CPMG editing are effective methods for removing proteins and phospholipids from plasma samples for quantitative NMR analysis of metabolites. However, careful consideration should be given to the specific metabolites of interest and their susceptibility to the sample treatment procedures. These findings contribute to the development of optimized sample preparation protocols for metabolomics studies using NMR spectroscopy. |
format | Online Article Text |
id | pubmed-10273206 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102732062023-06-17 Quantitative plasma profiling by (1)H NMR-based metabolomics: impact of sample treatment Madrid-Gambin, Francisco Oller, Sergio Marco, Santiago Pozo, Óscar J. Andres-Lacueva, Cristina Llorach, Rafael Front Mol Biosci Molecular Biosciences Introduction: There is evidence that sample treatment of blood-based biosamples may affect integral signals in nuclear magnetic resonance-based metabolomics. The presence of macromolecules in plasma/serum samples makes investigating low-molecular-weight metabolites challenging. It is particularly relevant in the targeted approach, in which absolute concentrations of selected metabolites are often quantified based on the area of integral signals. Since there are a few treatments of plasma/serum samples for quantitative analysis without a universally accepted method, this topic remains of interest for future research. Methods: In this work, targeted metabolomic profiling of 43 metabolites was performed on pooled plasma to compare four methodologies consisting of Carr-Purcell-Meiboom-Gill (CPMG) editing, ultrafiltration, protein precipitation with methanol, and glycerophospholipid solid-phase extraction (g-SPE) for phospholipid removal; prior to NMR metabolomics analysis. The effect of the sample treatments on the metabolite concentrations was evaluated using a permutation test of multiclass and pairwise Fisher scores. Results: Results showed that methanol precipitation and ultrafiltration had a higher number of metabolites with coefficient of variation (CV) values above 20%. G-SPE and CPMG editing demonstrated better precision for most of the metabolites analyzed. However, differential quantification performance between procedures were metabolite-dependent. For example, pairwise comparisons showed that methanol precipitation and CPMG editing were suitable for quantifying citrate, while g-SPE showed better results for 2-hydroxybutyrate and tryptophan. Discussion: There are alterations in the absolute concentration of various metabolites that are dependent on the procedure. Considering these alterations is essential before proceeding with the quantification of treatment-sensitive metabolites in biological samples for improving biomarker discovery and biological interpretations. The study demonstrated that g-SPE and CPMG editing are effective methods for removing proteins and phospholipids from plasma samples for quantitative NMR analysis of metabolites. However, careful consideration should be given to the specific metabolites of interest and their susceptibility to the sample treatment procedures. These findings contribute to the development of optimized sample preparation protocols for metabolomics studies using NMR spectroscopy. Frontiers Media S.A. 2023-06-02 /pmc/articles/PMC10273206/ /pubmed/37333016 http://dx.doi.org/10.3389/fmolb.2023.1125582 Text en Copyright © 2023 Madrid-Gambin, Oller, Marco, Pozo, Andres-Lacueva and Llorach. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Molecular Biosciences Madrid-Gambin, Francisco Oller, Sergio Marco, Santiago Pozo, Óscar J. Andres-Lacueva, Cristina Llorach, Rafael Quantitative plasma profiling by (1)H NMR-based metabolomics: impact of sample treatment |
title | Quantitative plasma profiling by (1)H NMR-based metabolomics: impact of sample treatment |
title_full | Quantitative plasma profiling by (1)H NMR-based metabolomics: impact of sample treatment |
title_fullStr | Quantitative plasma profiling by (1)H NMR-based metabolomics: impact of sample treatment |
title_full_unstemmed | Quantitative plasma profiling by (1)H NMR-based metabolomics: impact of sample treatment |
title_short | Quantitative plasma profiling by (1)H NMR-based metabolomics: impact of sample treatment |
title_sort | quantitative plasma profiling by (1)h nmr-based metabolomics: impact of sample treatment |
topic | Molecular Biosciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273206/ https://www.ncbi.nlm.nih.gov/pubmed/37333016 http://dx.doi.org/10.3389/fmolb.2023.1125582 |
work_keys_str_mv | AT madridgambinfrancisco quantitativeplasmaprofilingby1hnmrbasedmetabolomicsimpactofsampletreatment AT ollersergio quantitativeplasmaprofilingby1hnmrbasedmetabolomicsimpactofsampletreatment AT marcosantiago quantitativeplasmaprofilingby1hnmrbasedmetabolomicsimpactofsampletreatment AT pozooscarj quantitativeplasmaprofilingby1hnmrbasedmetabolomicsimpactofsampletreatment AT andreslacuevacristina quantitativeplasmaprofilingby1hnmrbasedmetabolomicsimpactofsampletreatment AT llorachrafael quantitativeplasmaprofilingby1hnmrbasedmetabolomicsimpactofsampletreatment |